Skip to main content

Immuron Ltd

IMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660046

No open-market purchases or sales by Immuron Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $82.2K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Immuron Ltd changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of IMRN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders440
Shares11.8K7.89K−3.90K (−33.1%)
Value$23.8K$15.6K−$8.20K (−34.4%)

New holders (0)

Institutions that held Immuron Ltd at the end of Q3 2023 but not at the end of Q2 2023.

None.

Sold out (0)

Institutions that held Immuron Ltd at the end of Q2 2023 and filed for Q3 2023 without it.

None.